Effect of (+/-)-2-[p-(2-thenoyl)phenyl] propionic acid (suprofen) on experimental allergic reactions.
The effects of (+/-)-2-[p-(2-thenoyl)phenyl] propionic acid (suprofen), a new anti-inflammatory agent, on experimental allergic reaction and antibody formation were examined. The action was compared with those of ketoprofen, ibuprofen, indomethacin, tranilast, chlorpheniramine, prednisolone and/or cyclophosphamide. Suprofen inhibited homologous PCA in rats, immunological histamine release from rat peritoneal mast cells and guinea pig lung tissues, Forssman cutaneous vasculitis (FCV) and the Arthus reaction in guinea pigs. The potency for inhibition of the PCA reaction was similar to that of ketoprofen and more potent than ibuprofen and trailast. As for the release of anaphylactic mediators, suprofen was less potent than tranilast in terms of histamine release, but not the release of the slow reacting substance of anaphylaxis (SRS-A). Suprofen inhibited FCA more potently than other nonsteroidal anti-inflammatory drugs (NSAID). The inhibition of the Arthus reaction by suprofen was similar to those of other NSAID and prednisolone. Suprofen hardly affected delayed hypersensitivity in guinea pigs and antibody (IgM or IgE) formation in mice or rats.
D000818:Animals; D000917:Antibody Formation / Q000187:drug effects*; D002199:Capillary Permeability / Q000187:drug effects; D005577:Forssman Antigen; D006168:Guinea Pigs; D006634:Histamine H1 Antagonists; D006967:Hypersensitivity / Q000188:drug therapy*; D006968:Hypersensitivity, Delayed / Q000188:drug therapy; D008297:Male; D010323:Passive Cutaneous Anaphylaxis / Q000187:drug effects; D010666:Phenylpropionates / Q000627:therapeutic use*; D051381:Rats; D011919:Rats, Inbred Strains; D013496:Suprofen / Q000494:pharmacology / Q000627:therapeutic use*; D018366:Vasculitis, Leukocytoclastic, Cutaneous / Q000188:drug therapy
D006634:Histamine H1 Antagonists; D010666:Phenylpropionates; D005577:Forssman Antigen; D013496:Suprofen